A recent article evaluates CG Oncology, Inc. in comparison to other top IPO stocks for 2025. Hamilton Lane co-CEO Erik Hirsch discusses factors affecting the IPO market, highlighting the need for diverse sectors and regulatory stability.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing